GE HealthCare Technologies (GEHC) Non-Current Debt (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Non-Current Debt came in at $10.1 billion in Q2 2026, down 1.77% YoY from $10.3 billion in Q2 2025, and little changed on a QoQ basis from $10.1 billion in Q1 2026.
GE HealthCare Technologies (GEHC) Non-Current Debt (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Non-Current Debt data on file, last reported at $10.1 billion in Q2 2026.
- Quarterly Non-Current Debt fell 1.77% year-over-year to $10.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.1 billion (down 1.77% YoY) and the FY2025 annual result came in at $10.0 billion, up 11.75% from the prior year.
- Non-Current Debt steadied at $10.1 billion in Q2 2026, from $10.1 billion in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $10.3 billion in Q3 2024 to a low of $8.2 billion in Q4 2022.
- A 5-year average of $9.7 billion and a median of $10.1 billion in 2026 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2024 — Non-Current Debt declined 9.7% — and 2026, when it advanced 15.7%.
- Tracing GEHC's Non-Current Debt over 5 years: stood at $8.2 billion in 2022, then grew by 14.46% to $9.4 billion in 2023, then declined by 5.2% to $9.0 billion in 2024, then advanced by 11.75% to $10.0 billion in 2025, then advanced by 0.9% to $10.1 billion in 2026.
- The last three Non-Current Debt figures came in at $10.1 billion (Q2 2026), $10.1 billion (Q1 2026), and $10.0 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 6.28 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.09 Bn |
| Mar 31, 2026 | 10.13 Bn |
| Dec 31, 2025 | 10.00 Bn |
| Sep 30, 2025 | 10.28 Bn |
| Jun 30, 2025 | 10.28 Bn |
| Mar 31, 2025 | 8.76 Bn |
| Dec 31, 2024 | 8.95 Bn |
| Sep 30, 2024 | 10.31 Bn |
| Jun 30, 2024 | 9.24 Bn |
| Mar 31, 2024 | 9.26 Bn |
| Dec 31, 2023 | 9.44 Bn |
| Sep 30, 2023 | 10.25 Bn |
| Jun 30, 2023 | 10.23 Bn |
| Mar 31, 2023 | 10.23 Bn |
| Dec 31, 2022 | 8.25 Bn |